Medpace Holdings, Inc. (MEDP) Income Statement
MEDP 2025 at a glance
Fiscal year ended December 31, 2025 · U.S. dollarsMEDP revenue and net income
Where MEDP's revenue goes
2025Each bar shows an amount and its share of revenue. MEDP kept 17.8% of revenue as net income.
MEDP profit margins
MEDP growth rates
to 2025| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | +20.0% | +20.1% | +22.3% | +21.6% |
| Gross profit | +15.9% | +20.7% | +22.2% | +17.1% |
| Operating income | +19.7% | +24.3% | +26.2% | +38.5% |
| Net income | +11.6% | +22.5% | +25.4% | — |
| EPS (diluted) | +20.8% | +27.5% | +31.0% | — |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
MEDP quarterly EPS vs estimates
Medpace beat the analyst EPS estimate in 8 of the last 8 quarters. Next report: October 21, 2026 (estimate $4.45).
MEDP income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.53B | $2.11B | $1.89B | $1.46B | $1.14B | $925.9M | $861.0M | $704.6M | $436.2M | $421.6M |
| Cost of revenue | $1.77B | $1.45B | $1.36B | $1.03B | $814.2M | $647.2M | $615.3M | $489.1M | $261.5M | $249.5M |
| Gross profit | $760.6M | $656.3M | $524.5M | $432.4M | $328.2M | $278.7M | $245.7M | $215.5M | $174.7M | $172.1M |
| Research & development | — | — | — | — | — | — | — | — | $0 | $0 |
| Sales, general & admin | $197.6M | $180.2M | $161.4M | $131.4M | $108.4M | $92.2M | $95.2M | $76.5M | $64.0M | $62.1M |
| Total operating expenses | $225.7M | $209.4M | $187.7M | $153.7M | $129.5M | $111.7M | $118.4M | $114.5M | $109.8M | $119.6M |
| Operating income | $534.9M | $446.9M | $336.8M | $278.7M | $198.6M | $167.0M | $127.3M | $101.0M | $64.9M | $52.5M |
| Interest income | — | — | — | — | — | — | $1.6M | $8.2M | $7.6M | $19.4M |
| Interest expense | — | $25.0M | $488,000 | $2.9M | $105,000 | $307,000 | $1.6M | $8.2M | $7.6M | $19.4M |
| Income before taxes | $542.4M | $475.9M | $335.7M | $282.9M | $201.9M | $168.5M | $124.8M | $94.0M | $56.9M | $22.0M |
| Income taxes | $91.3M | $71.5M | $52.9M | $37.5M | $20.0M | $23.1M | $24.4M | $20.8M | $17.8M | $8.5M |
| Net income | $451.1M | $404.4M | $282.8M | $245.4M | $181.8M | $145.4M | $100.4M | $73.2M | $39.1M | $13.4M |
| EBITDA | $570.5M | $505.2M | $362.5M | $308.1M | $223.1M | $186.6M | $150.5M | $139.8M | $111.0M | $99.5M |
| EPS (diluted) | $15.30 | $12.67 | $8.93 | $7.38 | $4.91 | $3.97 | $3.01 | $2.59 | $1.51 | $1.20 |
| Gross margin | 30.1% | 31.1% | 27.8% | 29.6% | 28.7% | 30.1% | 28.5% | 30.6% | 40.1% | 40.8% |
| Operating margin | 21.1% | 21.2% | 17.9% | 19.1% | 17.4% | 18.0% | 14.8% | 14.3% | 14.9% | 12.5% |
| Net margin | 17.8% | 19.2% | 15.0% | 16.8% | 15.9% | 15.7% | 11.7% | 10.4% | 9.0% | 3.2% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $707.3M | $706.6M | $708.5M | $659.9M | $603.3M | $558.6M | $536.6M | $533.3M | $528.1M | $511.0M | $498.4M | $492.5M |
| Cost of revenue | $505.7M | $510.3M | $503.1M | $463.0M | $423.3M | $380.2M | $358.3M | $364.3M | $374.3M | $355.9M | $361.6M | $359.3M |
| Gross profit | $201.6M | $196.3M | $205.3M | $196.9M | $180.0M | $178.3M | $178.3M | $169.0M | $153.8M | $155.1M | $136.8M | $133.2M |
| Sales, general & admin | $48.1M | $47.9M | $44.9M | $48.1M | $46.7M | $57.9M | $45.4M | $49.2M | $41.5M | $44.1M | $42.5M | $41.4M |
| Total operating expenses | $54.8M | $54.8M | $52.0M | $55.1M | $53.7M | $64.8M | $52.9M | $56.7M | $48.7M | $51.1M | $49.5M | $48.3M |
| Operating income | $146.8M | $141.5M | $153.3M | $141.8M | $126.3M | $113.5M | $125.4M | $112.3M | $105.2M | $104.1M | $87.3M | $84.9M |
| Interest expense | — | — | — | — | — | — | $7.9M | $7.5M | $5.5M | $4.1M | $1.8M | $105,000 |
| Income before taxes | $151.7M | $147.6M | $156.8M | $142.8M | $124.5M | $118.2M | $133.9M | $118.8M | $110.5M | $112.8M | $90.7M | $83.2M |
| Income taxes | $30.3M | $23.7M | $21.7M | $31.7M | $34.3M | $3.6M | $16.9M | $22.4M | $22.1M | $10.2M | $12.4M | $12.7M |
| Net income | $121.4M | $123.9M | $135.1M | $111.1M | $90.3M | $114.6M | $117.0M | $96.4M | $88.4M | $102.6M | $78.3M | $70.5M |
| EBITDA | $147.6M | $154.5M | $164.0M | $149.9M | $131.6M | $125.1M | $141.4M | $126.3M | $117.7M | $119.8M | $96.5M | $90.2M |
| EPS (diluted) | $4.25 | $4.28 | $4.67 | $3.86 | $3.10 | $3.67 | $3.68 | $3.01 | $2.76 | $3.22 | $2.46 | $2.24 |
| Gross margin | 28.5% | 27.8% | 29.0% | 29.8% | 29.8% | 31.9% | 33.2% | 31.7% | 29.1% | 30.4% | 27.4% | 27.0% |
| Operating margin | 20.8% | 20.0% | 21.6% | 21.5% | 20.9% | 20.3% | 23.4% | 21.1% | 19.9% | 20.4% | 17.5% | 17.2% |
| Net margin | 17.2% | 17.5% | 19.1% | 16.8% | 15.0% | 20.5% | 21.8% | 18.1% | 16.7% | 20.1% | 15.7% | 14.3% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in MEDP's financial statements (latest annual report filed February 10, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.
MEDP financial results
In fiscal year 2025 (ended December 31, 2025), Medpace reported revenue of $2.5 billion, up 20.0% from the year before. It had net income of $451.1 million (up 11.6%), a net profit margin of 17.8%. Diluted earnings per share came to $15.30. Over five years revenue grew at an average rate of 22.3% a year.
See the MEDP stock overview for the latest quote and news, or the MEDP chart for price history and technical indicators.
MEDP income statement FAQ
What is Medpace's annual revenue?
Medpace reported total revenue of $2.5 billion for fiscal year 2025, which ended on December 31, 2025. That was up 20.0% from $2.1 billion the previous year.
Is Medpace profitable?
Yes. Medpace reported net income of $451.1 million in fiscal 2025, a net profit margin of 17.8%; its operating margin was 21.1%.
What is Medpace's gross margin?
Medpace's gross margin was 30.1% in fiscal 2025: for every $100 of revenue, Medpace kept $30 after the direct cost of its products and services.
How fast is Medpace growing?
Revenue grew 22.3% a year on average over the last five fiscal years, from $925.9 million to $2.5 billion.
What are Medpace's earnings per share?
Medpace earned $15.30 per diluted share in fiscal 2025, compared with $12.67 a year earlier.
When will Medpace report its next earnings?
Medpace is expected to report results for the quarter ending September 30, 2026 on October 21, 2026 after the market closes.
When does Medpace's fiscal year end?
Medpace's fiscal year ends in December. The latest annual report covers the year ended December 31, 2025 and was filed on February 10, 2026.